You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新股暗盤收盤 | 啟明醫療(2500.HK)收漲18.18% 市值突破150億港元
格隆匯 12-09 18:38
格隆匯12月9日丨中國領先的經導管心臟瓣膜醫療器械企業啟明醫療-B(02500.HK)$暗盤高開12.12%,盤中衝高後持續震盪,收漲18.18%,報39港元,成交5225.6萬港元,最新總市值153.148億港元。公司2017年、2018年收益分別為1816.4萬、1.15億元人民幣。公司此次發售約7853.75萬股,其中香港發售3926.9萬股,國際發售3926.85萬股,每手500股,淨籌24.11億港元;香港公開發售獲312.42倍認購。根據弗若斯特沙利文的資料,按2018年TAVR產品植入量計,啟明在中國的市場份額為79.3%。其自主研發的產品VenusA-Valve是首個獲NMPA批准及在中國進行商業化的TAVR產品。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account